10-Q: Quarterly report
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 To Go Ex-Dividend On April 12th, 2024 With 0.53906 USD Dividend Per Share
April 4th - $HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026(HROWL.US)$ is trading ex-dividend on April 12th, 2024. Shareholders of record on April 15th, 2024 will receive 0.53906 USD dividend per
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 To Go Ex-Dividend On January 11th, 2024 With 0.53906 USD Dividend Per Share
January 4th - $HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026(HROWL.US)$ is trading ex-dividend on January 11th, 2024. Shareholders of record on January 15th, 2024 will receive 0.53906 USD dividen
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 To Go Ex-Dividend On October 12th, 2023 With 0.53906 USD Dividend Per Share
October 7th - $HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026(HROWL.US)$ is trading ex-dividend on October 12th, 2023. Shareholders of record on October 15th, 2023 will receive 0.53906 USD dividen
Harrow Prices $60 Million Stock Offering, Sees Q2 Revenue in Excess of $31M Above Consensus
Harrow Acquires US and Canadian Commercial Rights for Santen's Ophthalmic Products
HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026 To Go Ex-Dividend On July 13th, 2023 With 0.53906 USD Dividend Per Share
July 6th - $HARROW HEALTH INC 8.625% SENIOR NOTES DUE 2026(HROWL.US)$ is trading ex-dividend on July 13th, 2023. Shareholders of record on July 15th, 2023 will receive 0.53906 USD dividend per sha
Harrow Health, Inc. 8.625% Senior Notes Due 2026 (HROWL) to Issue Quarterly Dividend of $0.54 on April 30th
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL – Get Rating) announced a quarterly dividend on Wednesday, April 5th, Wall Street Journal reports. Shareholders of record on Saturday, Ap
ROSEN, Top Ranked Investor Counsel, Encourages Harrow Health, Inc. Investors to Inquire About Securities Class Action Investigation - HROW, HROWL, HROWM
Harrow Health, Inc. 8.625% Senior Notes Due 2026 (NASDAQ:HROWL) Sees Significant Growth in Short Interest
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL – Get Rating) was the recipient of a significant increase in short interest in the month of February. As of February 28th, there was shor
ROSEN, Global Investor Counsel, Encourages Harrow Health, Inc. Investors to Inquire About Securities Class Action Investigation - HROW, HROWL, HROWM
Short Interest in Harrow Health, Inc. 8.625% Senior Notes Due 2026 (NASDAQ:HROWL) Increases By 24.6%
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL – Get Rating) was the target of a large increase in short interest in the month of February. As of February 15th, there was short interes
ROSEN, A Top Ranked Law Firm, Encourages Harrow Health, Inc. Investors With Losses to Inquire About Securities Class Action Investigation - HROW, HROWL, HROWM
New York, New York--(Newsfile Corp. - March 3, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Harrow
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Harrow Health, Inc. Investors to Inquire About Securities Class Action Investigation HROW, HROWL, HROWM
Short Interest in Harrow Health, Inc. 8.625% Senior Notes Due 2026 (NASDAQ:HROWL) Grows By 200.0%
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL – Get Rating) was the recipient of a large growth in short interest in December. As of December 30th, there was short interest totalling
Harrow Health, Inc. 8.625% Senior Notes Due 2026 (HROWL) to Issue Quarterly Dividend of $0.54 on January 31st
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL – Get Rating) announced a quarterly dividend on Monday, January 9th, Wall Street Journal reports. Investors of record on Sunday, January
Harrow Health, Inc. 8.625% Senior Notes Due 2026 (NASDAQ:HROWL) Short Interest Down 25.6% in December
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL – Get Rating) was the recipient of a large drop in short interest during the month of December. As of December 15th, there was short int
Gates Foundation: up to $120 million to help low-income countries accelerate access to COVID-19 drugs
The Bill and Melinda Gates Foundation today pledged up to $120 million to help low-income countries accelerate access to Monopivir, an antiviral drug under development, as part of the foundation's efforts to fight the COVID-19 epidemic. Since the outbreak of the new crown, the Gates Foundation has provided $1.9 billion to improve access to vaccines, treatment and testing to support research and development, regulation, risk production and product delivery. Melinda French, co-chairman of the Bill and Melinda Gates Foundation
The global semiconductor shortage intensified, and the revenue of the top 10 chip manufacturers reached a record high in the first quarter
Sina Technology News reported on the evening of June 1, Beijing time, according to reports, the research company TrendForce released a report today saying that along with the intensification of the global semiconductor shortage, the revenue of the world's top 10 chip manufacturers also reached record highs in the first quarter of this year. The report shows that in the first quarter of 2021, the total revenue of the world's top 10 chip manufacturing companies reached US$22.75 billion, a record high. This move comes at a time when global chips are in short supply, and it is expected that this shortage will continue until 2023. TrendForce analysts said, “Because of all kinds of terminal devices
No Data